Up to 20% with Semaglutide and up to 27% with Tirzepatid Semaglutide and Tirzepatide are currently approved by the FDA for long-term use in the treatment of obesity
Tretinoin can cause temporary dryness, flaking, or purging during the adjustment period (niacinamide often helps minimize this)
It is a well-characterized molecule with a substantial research base
LL-37, also known as cathelicidin, is an antimicrobial peptide that is dramatically overexpressed in psoriatic skin
These substances, though common, are not always well-toleratedespecially by individuals with sensitivities, allergies, or chronic conditions At RX Releaf, we eliminate those risks by using single-dose, sterilized, preservative-free ingredients for every session
Cagrilintide and retatrutide are two investigational medicines being developed primarily for the treatment of obesity and type 2 diabetes